INTERHEART

INTERHEART was a landmark, global case-control study investigating the causes of myocardial infarction (heart attack) across diverse populations. Coordinated by the Population Health Research Institute at McMaster University and sponsored by the World Health Organization, it enrolled approximately 15,000 first-time heart attack patients and matched controls from 52 countries. Published in The Lancet in 2004, its findings demonstrated that a small set of modifiable risk factors accounted for the vast majority of heart attack risk worldwide, fundamentally reshaping preventive cardiology.

Background and study design

The study was conceived to address a critical gap in understanding the global patterns of cardiovascular disease, which was becoming a leading cause of death not only in industrialized nations like the United States and Western Europe but also increasingly in developing regions. Prior to INTERHEART, most major epidemiological studies, such as the Framingham Heart Study and the Seven Countries Study, were largely confined to specific geographic or ethnic populations. The principal investigators, including Dr. Salim Yusuf, designed a standardized case-control methodology to be implemented across 262 centers in Africa, Asia, Australia, Europe, the Middle East, and the Americas. Cases were individuals with a first acute myocardial infarction, confirmed by electrocardiogram and cardiac enzyme criteria, while controls were matched for age and sex but had no history of heart disease. Data collection involved detailed questionnaires and physical measurements to assess a wide range of lifestyle, psychosocial, and physiological factors.

Key findings

The primary analysis, published in the September 2004 issue of The Lancet, concluded that nine easily measured risk factors collectively accounted for over 90% of the population-attributable risk for a first heart attack in both men and women, across all geographic regions and ethnic groups. This finding was remarkably consistent, whether comparing populations in Canada, China, South Africa, or Colombia. The study powerfully demonstrated that the same fundamental risk factors were operative globally, challenging prior assumptions that causes might differ substantially by region or ethnicity. It also highlighted that abnormal blood lipids, specifically an elevated apolipoprotein B to apolipoprotein A-1 ratio, was the strongest single risk factor. The results provided robust, population-level evidence that heart attacks are largely preventable through modification of these key factors.

Risk factors identified

The nine key modifiable risk factors identified, in order of population-attributable risk, were: abnormal blood lipids (dyslipidemia), smoking, hypertension, diabetes mellitus, abdominal obesity, psychosocial factors (such as stress and depression), low daily consumption of fruits and vegetables, lack of regular physical activity, and no regular alcohol consumption. Protective factors were also noted, including a diet rich in fruits and vegetables and moderate physical activity. The study quantified the impact of these factors; for example, current smoking increased the risk of a heart attack three-fold, while the combination of smoking, dyslipidemia, and hypertension increased the risk more than ten-fold. The consistency of these associations across diverse cultures, from Japan to Saudi Arabia to Brazil, was a central and influential finding.

Global impact and significance

INTERHEART had an immediate and profound impact on global health policy and clinical guidelines. Its evidence provided a strong, unified scientific foundation for the World Health Organization's initiatives on non-communicable disease prevention and was incorporated into guidelines by major cardiology societies like the American Heart Association and the European Society of Cardiology. The study shifted the paradigm from a focus on high-risk individuals in wealthy nations to a global, population-based strategy emphasizing simple, low-cost interventions. It influenced major public health campaigns, such as those promoting tobacco control through the WHO Framework Convention on Tobacco Control and efforts to reduce trans fats in the food supply. The data also helped justify large-scale simple prevention programs in countries like India and Iran.

Criticisms and limitations

As a case-control study, INTERHEART was inherently susceptible to certain methodological limitations, including recall bias, where participants with a recent heart attack might recall past behaviors differently than healthy controls. While it established strong associations, it could not definitively prove causality for all factors, a strength more inherent in prospective cohort studies like the Nurses' Health Study. Some critics noted that the selection of controls from hospital settings, rather than the general community, could potentially introduce selection bias. Furthermore, while the study spanned 52 countries, some regions, particularly parts of Sub-Saharan Africa, remained underrepresented. Despite these limitations, the extraordinary consistency of its results across hundreds of centers and its alignment with findings from other study designs have led the broader scientific community to regard its core conclusions as robust and transformative.

Category:Medical research studies Category:Epidemiology Category:Cardiology